Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

P Yan, J Wang, B Yue, X Wang - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Osteosarcoma, a rare primary bone cancer, presents diverse molecular aberrations that
underscore its complexity. Despite the persistent endeavors by researchers, the limited …

Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application

Y Zhang, M Xu, Y Ren, Y Ba, S Liu, A Zuo, H Xu… - Molecular Cancer, 2024 - Springer
Tertiary lymphoid structures (TLS) are clusters of immune cells that resemble and function
similarly to secondary lymphoid organs (SLOs). While TLS is generally associated with an …

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer

X He, Y Peng, G He, H Ye, L Liu, Q Zhou, J Shi… - Journal of Translational …, 2023 - Springer
Background The effectiveness of immune checkpoint inhibitors in treating gallbladder
cancer (GBC) remains unsatisfactory. Recently, several new immune checkpoints have …

Immunotherapy in Sarcoma: Current Data and Promising Strategies

GE Wood, C Meyer, F Petitprez… - American Society of …, 2024 - ascopubs.org
Traditionally sarcomas have been considered immunologically quiet tumours, with low
tumour mutational burden (TMB) and an immunosuppressive tumour microenvironment …

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy

D Chen, L Xu, M Xuan, Q Chu… - Clinical and Translational …, 2024 - Wiley Online Library
Recent studies have established the pivotal roles of patient‐derived tumour organoids
(PDTOs), innovative three‐dimensional (3D) culture systems, in various biological and …

Immunotherapy and Radiotherapy Combinations for Sarcoma

QS Zhang, JP Hayes, V Gondi, SM Pollack - Seminars in Radiation …, 2024 - Elsevier
Sarcomas are a heterogeneous group of bone and soft tissue tumors. Survival outcomes for
advanced (unresectable or metastatic) disease remain poor, so therapeutic improvements …

Perioperative immunotherapy for esophageal squamous cell carcinoma

DD Wei, JM Fang, HZ Wang, J Chen, S Kong… - Frontiers in …, 2024 - frontiersin.org
Esophageal squamous cell carcinoma (ESCC) is the main prevalent histological subtype
and accounts for 85% of esophageal cancer cases worldwide. Traditional treatment for …

[HTML][HTML] CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis

Y Ko, SY Park, JW Park, JH Kim, HG Kang, JA Lee - Cells, 2024 - mdpi.com
CD47 is expressed on cell surfaces and acts as a “don't eat me” signal by interacting with
signal-regulatory protein-α on the macrophage surface. Some cancer cells express CD47 …

Qingfei mixture mitigates immunosuppression of tumor microenvironment in non-small cell lung cancer by blocking stat1/Ido1-mediated tryptophan-kynurenine …

Z Chen, YH Ding, L Shao, XM Ji, X Qian, AQ Zhang - Heliyon, 2024 - cell.com
Abstract Programmed death-1 (PD-1) acts as a T cell checkpoint and is important in
controlling T cell exhaustion. Blocking the intercommunication across PD-1 and PD-L1 is …

[HTML][HTML] Immune pathway through endometriosis to ovarian cancer

MS Calmon, FFB Lemos, MS Luz… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Endometriosis is an estrogen-dependent inflammatory disease, defined by the presence of
functional endometrial tissue outside of the uterine cavity. This disease is one of the main …